PARIMI, Sunil et al. Pain response in a population-based study of radium-223 (Ra223) for metastatic castration-resistant prostate cancer. Canadian Urological Association Journal, [S. l.], v. 13, n. 10, p. E311–6, 2018. DOI: 10.5489/cuaj.5685. Disponível em: https://cuaj.ca/index.php/journal/article/view/5685. Acesso em: 5 may. 2026.